Warfarin Sodium shortage — CA supply status & alternatives

Warfarin Sodium

—

🇦🇺 AUST R 12511 · Mylan Health Pty Ltd

In supply · Australia

Apo-Warfarin

In supply · 🇦🇺 Australia · short in🇺🇸 US🇨🇦 CA🇮🇪 IE🌐 MY🇸🇬 SG

In supply in Australia

Reading today’s signals…

✓ Can I substitute?

In supply

no shortage substitution needed

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Active ingredient (INN)	Warfarin Sodium

Brand names	Apo-Warfarin

Therapeutic category	Auto-created by Health Canada — Drug Shortages Database scraper

Controlled substance	No

Marketing-authorisation holders	ROSEMONT PHARMACEUTICALS LIMITED, TEVA PHARMACEUTICALS USA, INC., Mylan Health Pty Ltd

Registrations on file	30

Patient information leaflet (PIL)	Not on file

Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 Australia · awaiting price ingest

🇦🇺 AU

Ex-manufacturer

—

Dispensed (DPMQ)

—

Pack

—

Not yet captured for Australia

Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.

Other markets

🇺🇸 US

US$0.09

Acquisition

Global API supply base 🇺🇸 FDA Drug Master Files · active Type II

10 API manufacturers

Manufacturers with an active Type II Drug Master File — i.e. cleared to supply this active ingredient into the US market. A proxy for how concentrated the global manufacturing base is.

Low concentration risk

Chieron Active Ingredients Private LTDZydus Lifesciences LTDApotex INCTapi Nl BVTaro Pharmaceutical Industries LTDIpca Laboratories LTD+4 more

Manufacturing countries: India, Canada, Israel · Source: FDA List of Drug Master Files

Recalls official enforcement reports

🇺🇸

WARFARIN SODIUM

CARDINAL HEALTHCARE · Jan 2022

Class IIdetails ↗

🇺🇸

WARFARIN SODIUM

CARDINAL HEALTHCARE · Jan 2022

Class IIdetails ↗

🇺🇸

WARFARIN SODIUM

Taro Pharmaceuticals U.S.A., Inc. · Aug 2014

Class IIIdetails ↗

Registration recordmarketing-authorisation holders

Registrations & marketing-authorisation holders30 registrations · 3 MA holders

Product	Strength	Form	Market	MA holder	Status
WARFARIN SODIUM 1MG/1ML ORAL SUSPENSION	1MG	suspension	🇬🇧 GB	ROSEMONT PHARMACEUTICALS LIMITED	Active
Warfarin Sodium	1mg/1	tablet	🇺🇸 US	TEVA PHARMACEUTICALS USA, INC.	Active
Warfarin Sodium	2mg/1	tablet	🇺🇸 US	TEVA PHARMACEUTICALS USA, INC.	Active
Warfarin Sodium	2.5mg/1	tablet	🇺🇸 US	TEVA PHARMACEUTICALS USA, INC.	Active
Warfarin Sodium	3mg/1	tablet	🇺🇸 US	TEVA PHARMACEUTICALS USA, INC.	Active
Warfarin Sodium	4mg/1	tablet	🇺🇸 US	TEVA PHARMACEUTICALS USA, INC.	Active
Warfarin Sodium	6mg/1	tablet	🇺🇸 US	TEVA PHARMACEUTICALS USA, INC.	Active
Warfarin Sodium	10mg/1	tablet	🇺🇸 US	TEVA PHARMACEUTICALS USA, INC.	Active
Warfarin Sodium	5mg/1	tablet	🇺🇸 US	TEVA PHARMACEUTICALS USA, INC.	Active
Warfarin Sodium	7.5mg/1	tablet	🇺🇸 US	TEVA PHARMACEUTICALS USA, INC.	Active
MAREVAN warfarin sodium	1mg	—	🇦🇺 AU	Mylan Health Pty Ltd	Active
MAREVAN warfarin sodium	3mg	—	🇦🇺 AU	Mylan Health Pty Ltd	Active
MAREVAN warfarin sodium	5mg	—	🇦🇺 AU	Mylan Health Pty Ltd	Active
COUMADIN warfarin sodium	2mg	—	🇦🇺 AU	Mylan Health Pty Ltd	Active
COUMADIN warfarin sodium	1mg	—	🇦🇺 AU	Mylan Health Pty Ltd	Active

+15 more registrations on file

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.